Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Joint Stock Company Kaspi.kz Lawsuit - KSPI - Kaspi.kz ( NASDAQ:KSPI )
NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Joint Stock Company Kaspi.kz ( "Joint Stock Company Kaspi.kz" or the "Company" ) KSPI of a class action securities lawsuit.
EVI Industries' Q2 Earnings Fall Y/Y on Higher Costs, Stock Down 10%
EVI's fiscal Q2 earnings fall year over year despite record revenues, as higher SG&A costs and delayed industrial sales offset gains from strong gross margins and backlog growth.
Sun Life Financial Q4 Earnings & Revenues Miss Estimates, Down Y/Y
SLF's fourth-quarter earnings reflect soft results in Group - Health & Protection.
Moody's Projects High Single-Digit Revenue Increase For 2025, Q4 Revenue Climbs 13% - Moodys ( NYSE:MCO )
Moody's Q4 revenue rose 13% to $1.67B, driven by an 18% increase in Investors Service revenue. Adjusted EPS reached $2.62, surpassing estimates, as Analytics revenue grew 8%. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights.
Class Action Filed Against Crocs, Inc. ( CROX ) - March 24, 2025 Deadline to Join - Contact Levi & Korsinsky - Crocs ( NASDAQ:CROX )
NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Crocs, Inc. ( "Crocs" or the "Company" ) CROX of a class action securities lawsuit.
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Applied Therapeutics ( NASDAQ:APLT )
NEW YORK, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. ( "Applied Therapeutics" or the "Company" ) APLT of a class action securities lawsuit.
Here is Why Growth Investors Should Buy Graham ( GHM ) Now
Graham (GHM) could produce exceptional returns because of its solid growth attributes.
Here is Why Growth Investors Should Buy Harmony Biosciences ( HRMY ) Now
Harmony Biosciences (HRMY) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Looking for a Growth Stock? 3 Reasons Why EnerSys ( ENS ) is a Solid Choice
EnerSys (ENS) could produce exceptional returns because of its solid growth attributes.








